glp 1 for parkinson's Glucagon-like peptide-1 (GLP-1) receptor agonists and neuroinflammation: Implications neurodegenerative disease treatment GLP-1a: Going beyond Traditional Use

Experiencing vertigo or dizziness from GLP-1 Injections

Get fast relief from multiple causes of nausea with Advanced Herbals motion-related nausea relief from the makers of Dramamine

A new survey suggests about three million Canadian adults are currently taking GLP-1 drugs such as Ozempic or Mounjaro and that many more would like to, but cost is a barrier.

A switch is not always a dropout

Five clinical trials in type 2-diabetic subjects (SURPASS 15) have shown that tirzepatide at 515 mg per week reduces both HbA1c (1.24 to 2.58%) and body weight (5.411.7 kg) by amounts unprecedented for a single agent

Pharmaceutical representative was part of a major announcement to make weight loss drugs more affordable